165 related articles for article (PubMed ID: 29566279)
21. Elevated methylation of CMTM3 promoter in the male laryngeal squamous cell carcinoma patients.
Shen Z; Chen X; Li Q; Zhou C; Xu Y; Yu R; Ye H; Li J; Duan S
Clin Biochem; 2016 Nov; 49(16-17):1278-1282. PubMed ID: 27521994
[TBL] [Abstract][Full Text] [Related]
22. Promoter hypermethylation-induced transcriptional down-regulation of the gene MYCT1 in laryngeal squamous cell carcinoma.
Yang M; Li W; Liu YY; Fu S; Qiu GB; Sun KL; Fu WN
BMC Cancer; 2012 Jun; 12():219. PubMed ID: 22672838
[TBL] [Abstract][Full Text] [Related]
23. ESRRG promoter hypermethylation as a diagnostic and prognostic biomarker in laryngeal squamous cell carcinoma.
Shen Z; Hu Y; Zhou C; Yuan J; Xu J; Hao W; Deng H; Ye D
J Clin Lab Anal; 2019 Jul; 33(6):e22899. PubMed ID: 31002184
[TBL] [Abstract][Full Text] [Related]
24. Combined deletion and DNA methylation result in silencing of FAM107A gene in laryngeal tumors.
Kiwerska K; Szaumkessel M; Paczkowska J; Bodnar M; Byzia E; Kowal E; Kostrzewska-Poczekaj M; Janiszewska J; Bednarek K; Jarmuż-Szymczak M; Kalinowicz E; Wierzbicka M; Grenman R; Szyfter K; Marszałek A; Giefing M
Sci Rep; 2017 Jul; 7(1):5386. PubMed ID: 28710449
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of the methylation of Wnt pathway antagonists-CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling-ZIC1, ZIC4, and HHIP in head and neck squamous cell carcinomas.
Paluszczak J; Wiśniewska D; Kostrzewska-Poczekaj M; Kiwerska K; Grénman R; Mielcarek-Kuchta D; Jarmuż-Szymczak M
Clin Oral Investig; 2017 Jun; 21(5):1777-1788. PubMed ID: 27553089
[TBL] [Abstract][Full Text] [Related]
26. The Clinical Signification of Claudin-11 Promoter Hypermethylation for Laryngeal Squamous Cell Carcinoma.
Shen Z; Cao B; Lin L; Zhou C; Ye D; Qiu S; Li Q; Cui X
Med Sci Monit; 2017 Jul; 23():3635-3640. PubMed ID: 28743857
[TBL] [Abstract][Full Text] [Related]
27. Protocadherin 17 acts as a tumour suppressor inducing tumour cell apoptosis and autophagy, and is frequently methylated in gastric and colorectal cancers.
Hu X; Sui X; Li L; Huang X; Rong R; Su X; Shi Q; Mo L; Shu X; Kuang Y; Tao Q; He C
J Pathol; 2013 Jan; 229(1):62-73. PubMed ID: 22926751
[TBL] [Abstract][Full Text] [Related]
28. SSTR2 promoter hypermethylation is associated with the risk and progression of laryngeal squamous cell carcinoma in males.
Shen Z; Chen X; Li Q; Zhou C; Li J; Ye H; Duan S
Diagn Pathol; 2016 Jan; 11():10. PubMed ID: 26796520
[TBL] [Abstract][Full Text] [Related]
29. Protocadherin-17 promoter methylation in serum-derived DNA is associated with poor prognosis of bladder cancer.
Luo ZG; Li ZG; Gui SL; Chi BJ; Ma JG
J Int Med Res; 2014 Feb; 42(1):35-41. PubMed ID: 24366498
[TBL] [Abstract][Full Text] [Related]
30. The involvement of CHD5 hypermethylation in laryngeal squamous cell carcinoma.
Wang J; Chen H; Fu S; Xu ZM; Sun KL; Fu WN
Oral Oncol; 2011 Jul; 47(7):601-8. PubMed ID: 21636313
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of thrombospondin-1 by DNA hypermethylation is associated with tumor progression in laryngeal squamous cell carcinoma.
Huang C; Zhou X; Li Z; Liu H; He Y; Ye G; Huang K
Mol Med Rep; 2016 Sep; 14(3):2489-96. PubMed ID: 27485791
[TBL] [Abstract][Full Text] [Related]
32. Protocadherin20 Acts as a Tumor Suppressor Gene: Epigenetic Inactivation in Nasopharyngeal Carcinoma.
Chen T; Long B; Ren G; Xiang T; Li L; Wang Z; He Y; Zeng Q; Hong S; Hu G
J Cell Biochem; 2015 Aug; 116(8):1766-75. PubMed ID: 25736877
[TBL] [Abstract][Full Text] [Related]
33. PCDH17 gene promoter methylation status in a cohort of Egyptian women with epithelial ovarian cancer.
Elsharkawi SM; Elkaffash D; Moez P; El-Etreby N; Sheta E; Taleb RSZ
BMC Cancer; 2023 Jan; 23(1):89. PubMed ID: 36698136
[TBL] [Abstract][Full Text] [Related]
34. Aberrant methylation-mediated downregulation of lncRNA SSTR5-AS1 promotes progression and metastasis of laryngeal squamous cell carcinoma.
Wang B; Zhao L; Chi W; Cao H; Cui W; Meng W
Epigenetics Chromatin; 2019 Jun; 12(1):35. PubMed ID: 31196171
[TBL] [Abstract][Full Text] [Related]
35. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
De Schutter H; Geeraerts H; Verbeken E; Nuyts S
Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
[TBL] [Abstract][Full Text] [Related]
36. LMX1B mRNA expression and its gene body CpG methylation are valuable prognostic biomarkers for laryngeal squamous cell carcinoma.
Fan L; Zhang A; Deng P
Biomed Pharmacother; 2019 Sep; 117():109174. PubMed ID: 31387183
[TBL] [Abstract][Full Text] [Related]
37. Aberrant DNA hypermethylation-silenced LINC00886 gene accelerates malignant progression of laryngeal carcinoma.
Lan L; Cao H; Chi W; Meng W; Zhao L; Cui W; Wang B
Pathol Res Pract; 2020 Apr; 216(4):152877. PubMed ID: 32111441
[TBL] [Abstract][Full Text] [Related]
38. Aberrant methylation of PCDH17 gene in high-grade serous ovarian carcinoma.
Baranova I; Kovarikova H; Laco J; Dvorak O; Sedlakova I; Palicka V; Chmelarova M
Cancer Biomark; 2018; 23(1):125-133. PubMed ID: 29991130
[TBL] [Abstract][Full Text] [Related]
39. Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients.
Pierini S; Jordanov SH; Mitkova AV; Chalakov IJ; Melnicharov MB; Kunev KV; Mitev VI; Kaneva RP; Goranova TE
Head Neck; 2014 Aug; 36(8):1103-8. PubMed ID: 23804521
[TBL] [Abstract][Full Text] [Related]
40. Protocadherin 17 promoter methylation in tumour tissue from patients with bladder transitional cell carcinoma.
Wang XB; Lin YL; Li ZG; Ma JH; Li J; Ma JG
J Int Med Res; 2014 Apr; 42(2):292-9. PubMed ID: 24567353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]